To analyze the prognostic factors of 5-year survival and 10-year survival in hepatocellular carcinoma  patients, and to explore the reasons for long-term survival and provide choice of treatment modalities for HCC
Although several combinations of EGFR inhibitors with chemotherapy demonstrate inhibition of tumor-induced angiogenesis, tumor cell apoptosis, and regression in xenograft models, these benefits remain to be confirmed
final ACT for standard of care in anal cancer?
